4.3 Article

Prescribe to Save Lives: Improving Buprenorphine Prescribing Among HIV Clinicians

Related references

Note: Only part of the references are listed.
Article Health Care Sciences & Services

Prevalence and Medication Treatment of Opioid Use Disorder Among Primary Care Patients with Hepatitis C and HIV

Judith Tsui et al.

Summary: This study investigated the prevalence of diagnosed OUD and treatment among primary care patients with HCV or HIV, finding that patients with HCV and HIV were more likely to have OUD compared to those without, and HIV patients were less likely to receive medication treatment for OUD.

JOURNAL OF GENERAL INTERNAL MEDICINE (2021)

Article Substance Abuse

Socio-ecological and pharmacy-level factors associated with buprenorphine stocking at pharmacies in New York City

Phillip L. Marotta et al.

Summary: This study identified factors at both the pharmacy and neighborhood level that are associated with stocking buprenorphine. Pharmacy-level factors such as private consultation spaces and availability of naloxone were linked to buprenorphine stocking, while neighborhood-level factors like high poverty rates and rates of uninsured residents were also associated with buprenorphine availability.

INTERNATIONAL JOURNAL OF DRUG POLICY (2021)

Article Substance Abuse

It will end in tiers: A strategy to include dabblers in the buprenorphine workforce after the X-waiver

Brendan Saloner et al.

Summary: Buprenorphine is a gold standard medication for treating opioid use disorder, proven to prevent overdose and improve quality of life. The X-waiver allowing clinicians to prescribe buprenorphine in office-based settings is expected to be repealed in the United States, necessitating various strategies to establish a new treatment system.

SUBSTANCE ABUSE (2021)

Article Immunology

The Effect of Buprenorphine on Human Immunodeficiency Virus Viral Suppression

Jongyeon Kim et al.

Summary: The study found that initiating BUP in PLWH led to an increase in viral suppression, regardless of whether they were on ART treatment, indicating the importance of BUP in promoting viral suppression for individuals with opioid use disorder.

CLINICAL INFECTIOUS DISEASES (2021)

Article Substance Abuse

Pharmacy-related buprenorphine access barriers: An audit of pharmacies in counties with a high opioid overdose burden

Neda J. Kazerouni et al.

Summary: In US counties with high opioid-related mortality rates, approximately one in five pharmacies indicated they would not dispense buprenorphine. Independent pharmacies and pharmacies in Southern states were more likely to restrict buprenorphine availability. Pharmacy-directed interventions may be needed to ensure timely access to buprenorphine for individuals with opioid use disorder.

DRUG AND ALCOHOL DEPENDENCE (2021)

Article Substance Abuse

Provider Continuity in the Prescribing of Buprenorphine/Naloxone Within Medicare Part D

Justin C. Strickland et al.

Summary: Efforts to increase initial prescribing of buprenorphine have led to a growing number of providers prescribing the medication, with the majority prescribing to 10 or fewer beneficiaries. Most providers who prescribe buprenorphine continue to do so in the following year, although the rate of continuous prescribing is only 59.4%. Female providers and those in clinical neuroscience specialties showed higher discontinuation rates, while those with higher beneficiary loads and in states with increasing overdose mortality rates exhibited lower rates of discontinuation.

JOURNAL OF ADDICTION MEDICINE (2021)

Article Public, Environmental & Occupational Health

HIV Pre-exposure Prophylaxis and Buprenorphine at a Drug Detoxification Center During the Opioid Epidemic: Opportunities and Challenges

Sabrina A. Assoumou et al.

Summary: This study surveyed 200 individuals at a drug detoxification center to assess their interest in PrEP and buprenorphine, finding that despite low awareness among drug injectors, a majority were interested in PrEP. Interest in buprenorphine was higher among males. The results suggest opportunities for implementing PrEP and buprenorphine within drug detoxification centers.

AIDS AND BEHAVIOR (2021)

Article Immunology

Infectious Complications of Addiction: A Call for a New Subspecialty Within Infectious Diseases

David P. Serota et al.

CLINICAL INFECTIOUS DISEASES (2020)

Article Health Care Sciences & Services

Buprenorphine Treatment By Primary Care Providers, Psychiatrists, Addiction Specialists, And Others

Mark Olfson et al.

HEALTH AFFAIRS (2020)

Editorial Material Medicine, General & Internal

When Prescribing Isn't Enough - Pharmacy-Level Barriers to Buprenorphine Access

Hannah L. F. Cooper et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Infectious Diseases

Medications for Treatment of Opioid Use Disorder among Persons Living with HIV

Laura Fanucchi et al.

CURRENT HIV/AIDS REPORTS (2019)

Article Public, Environmental & Occupational Health

Integrated outpatient treatment of opioid use disorder and injection-related infections: A description of a new care model

Laura C. Fanucchi et al.

PREVENTIVE MEDICINE (2019)

Article Immunology

Integration of care for HIV and opioid use disorder

Benjamin J. Oldfield et al.

Article Public, Environmental & Occupational Health

Policy Pathways to Address Provider Workforce Barriers to Buprenorphine Treatment

Rebecca L. Haffajee et al.

AMERICAN JOURNAL OF PREVENTIVE MEDICINE (2018)

Article Infectious Diseases

The Syndemic of Opioid Misuse, Overdose, HCV, and HIV: Structural-Level Causes and Interventions

David C. Perlman et al.

CURRENT HIV/AIDS REPORTS (2018)

Article Substance Abuse

Vermont Hub-and-Spoke Model of Care for Opioid Use Disorder: Development, Implementation, and Impact

John R. Brooklyn et al.

JOURNAL OF ADDICTION MEDICINE (2017)

Review Medicine, General & Internal

Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies

Luis Sordo et al.

BMJ-BRITISH MEDICAL JOURNAL (2017)

Review Medicine, General & Internal

Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies

Luis Sordo et al.

BMJ-BRITISH MEDICAL JOURNAL (2017)

Article Health Policy & Services

HIV-infected individuals who use alcohol and other drugs, and virologic suppression

Seonaid Nolan et al.

AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV (2017)

Article Substance Abuse

Integrated HIV care is associated with improved engagement in treatment in an urban methadone clinic

Claire Simeone et al.

ADDICTION SCIENCE & CLINICAL PRACTICE (2017)

Letter Medicine, General & Internal

Physician Capacity to Treat Opioid Use Disorder With Buprenorphine-Assisted Treatment

Bradley D. Stein et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)

Review Substance Abuse

A review of a national training initiative to increase provider use of MAT to address the opioid epidemic

Frances R. Levin et al.

AMERICAN JOURNAL ON ADDICTIONS (2016)

Article Pharmacology & Pharmacy

Physician-pharmacist collaborative care model for buprenorphine-maintained opioid-dependent patients

Bethany A. DiPaula et al.

JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION (2015)

Article Health Policy & Services

Patient and provider priorities for self-reported domains of HIV clinical care

Rob J. Fredericksen et al.

AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV (2015)

Article Immunology

Integration of Buprenorphine/Naloxone Treatment into HIV Clinical Care: Lessons From the BHIVES Collaborative

Linda Weiss et al.

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2011)

Article Immunology

Drug Treatment Outcomes Among HIV-Infected Opioid-Dependent Patients Receiving Buprenorphine/Naloxone

David A. Fiellin et al.

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2011)

Article Health Care Sciences & Services

The Physician Clinical Support System-Buprenorphine (PCSS-B): a Novel Project to Expand/Improve Buprenorphine Treatment

James E. Egan et al.

JOURNAL OF GENERAL INTERNAL MEDICINE (2010)

Article Psychology, Clinical

Factors affecting willingness to provide buprenorphine treatment

Julie Netherland et al.

JOURNAL OF SUBSTANCE ABUSE TREATMENT (2009)

Article Health Care Sciences & Services

Barriers to obtaining waivers to prescribe buprenorphine for opioid addiction treatment among HIV physicians

Chinazo O. Cunningham et al.

JOURNAL OF GENERAL INTERNAL MEDICINE (2007)

Review Immunology

Models for integrating buprenorphine therapy into the primary HIV care setting

S Basu et al.

CLINICAL INFECTIOUS DISEASES (2006)

Article Substance Abuse

Performance of alcohol and safer sex change rulers compared with readiness to change questionnaires

JW LaBrie et al.

PSYCHOLOGY OF ADDICTIVE BEHAVIORS (2005)

Article Medicine, General & Internal

A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence.

RE Johnson et al.

NEW ENGLAND JOURNAL OF MEDICINE (2000)